MSD has been present in the Asia Pacific for some 60 years
and currently employs about 17,000 people.



The Asia Pacific is a leading growth driver for MSD within the Emerging Markets. Headquartered in Singapore, MSD's Asia Pacific operations span 14 diverse geographies encompassing Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Taiwan, Thailand, and Vietnam.

Over the coming decade, most of the world's pharmaceutical growth will come from the Emerging Markets, including the Asia Pacific. Driving performance in these high-growth markets is a priority for MSD, and our vision for the Asia Pacific focuses on the following strategies:

• Core Brands

  • • Achieve market leadership
  • • New Product Launches

  • • Accelerate time to market
  • • Ensure successful product launches
  • • Diversified Portfolio

  • • Grow our diversified products through new, innovative business models
  • • Innovative Branded Generics

  • • Develop new country strategies and business models to launch and commercialize innovative branded generics.